Women are less successful at receiving funds for research if the application reviewer is asked to evaluate the principal investigator, rather than the quality of the science, according to research published in The Lancet.

As the rising drug price issue has taken hold of the healthcare debate in the U.S., Democrats in Congress have introduced a bill that would allow Medicare to negotiate drug prices. 

The price for a drug that treats Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder that impacts strength and impairs walking, went from cost-free to the price of a house—$375,000 to be exact. 

Here are some of the top stories from around the web covering healthcare fraud and ethics issues.

Veterans are waiting a long time to receive care when they arrive at the emergency room of a Department of Veterans Affairs (VA) hospital, according to a recent analysis from USA Today. 

Anthem, the second largest health insurer in the nation, is facing a class action lawsuit for allegedly misleading thousands of Georgia consumers during the 2018 open enrollment period.

Walmart is allowing its employees to see a provider for only $4 but the visitation has to be through telemedicine, according to a report from the Associated Press.

Approximately two-thirds of U.S.-based hospitals and acute-care facility leaders believe diagnosis-related group (DRG) optimization is still a problem that needs to be solved in revenue cycle management, according to a recent survey conducted by BESLER and HIMSS Media.

Amid a major period of consolidation in the healthcare space, health systems have grown so large that using a patient’s name or date of birth isn’t a good identifier anymore. Instead, hospitals are turning to biometric systems, which use fingerprints or other physical characteristics to identify people, The Wall Street Journal reported.

Mayo Clinic has teamed up with Fortune 500 company Leidos in a strategic collaboration to develop and market tools, technologies and therapeutics to engage patients and families in their care.

Oscar Health, the New York-based startup health insurance provider with more than $1 billion in funding, has named Sid Sankaran as its new chief financial officer, effective March 1.

Healthcare executives are bullish on the financial performance of their own organizations looking into 2019, but they are less enthusiastic about the sector as a whole, according to a recent survey from J.P. Morgan.